世界の麻酔および呼吸装置の市場規模は、2024年に563億米ドルと推定され、2025年から2033年にかけて5.6%のCAGRで成長し、2033年までに915億米ドルに達すると予想されます。この市場は、閉塞性睡眠時無呼吸症候群(OSA)や慢性閉塞性肺疾患(COPD)などの呼吸器疾患の発生率の増加、急速な都市化、外科手術の増加、汚染レベル、高齢者人口、喫煙人口によって牽引されています。
目次
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product outlook
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.1.1. Rise In Chronic Respiratory Diseases And Geriatric Population
3.1.1.2. Technological Advancements
3.1.1.3. Supportive Initiatives by Government and Private Organizations
3.1.2. Market Restraint analysis
3.1.2.1. Product Recalls & Failure
3.1.2.2. Complexity of Modern Anesthesia and Respiratory Machines
3.1.3. Market Opportunities
3.2. Anesthesia and Respiratory Devices Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis
4.1. Product Type Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Brain Computer Interface Market by Product Type Outlook
4.3.1. Anesthesia Devices
4.3.1.1. Anesthesia Devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1. Anesthesia Machines
4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.2. Anesthesia Workstation
4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3. Anesthesia Delivery Machines
4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3.2. Portable Anesthesia Delivery Machine
4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3.3. Standalone Anesthesia Delivery Machine
4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.4. Anesthesia Ventilators
4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.5. Anesthesia Monitors
4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2. Anesthesia Disposables
4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2.2. Anesthesia Masks
4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2.3. Anesthesia Accessories
4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2. Respiratory Devices
4.3.2.1. Respiratory devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1. Respiratory Equipment
4.3.2.1.1.1. Respiratory Equipment’s market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2. Humidifiers
4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.2. Heat Humidifiers
4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.3. Heated wire breathing circuits
4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.4. Heat Exchangers
4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.5. Pass Over Humidifiers
4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3. Nebulizers
4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.2. Pneumatic nebulizers
4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.3. Mesh nebulizers
4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.4. Ultrasonic nebulizers
4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4. Oxygen Concentrators
4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4.2. Fixed Oxygen Concentrators
4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4.3. Portable Oxygen Concentrators
4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5. Positive airway pressure devices
4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5.2. Bi-level positive airway pressure devices
4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5.3. Continuous positive airway pressure devices
4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.6. Reusable resuscitators
4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7. Ventilators
4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7.2. Adult Ventilators
4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7.3. Neonatal Ventilators
4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8. Respiratory inhalers
4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8.2. Dry Powdered Inhalers
4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8.3. Metered Dose Inhalers
4.3.2.1.1.8.3.1. Metered Dose Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9. Respiratory disposable
4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.2. Disposable Oxygen Mask
4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.3. Resuscitators
4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.4. Tracheostomy Tubes
4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.5. Oxygen Cannula
4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10. Respiratory measurement devices
4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.2. Pulse oximetry systems
4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.3. Capnographs
4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.4. Spirometers
4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.5. Peak flowmeters
4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product
5.1. Regional Market Share Analysis, 2024 & 2033
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Norway
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. China
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share/position analysis, 2024
6.4. Company Profiles
6.4.1. Medtronic
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Teleflex Incorporated
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Koninklijke Philips N.V.
6.4.3.1. Company Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Drägerwerk AG & Co. KGaA
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Getinge AB.
6.4.5.1. Company Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Smiths Group plc
6.4.6.1. Company Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Fisher & Paykel Healthcare Limited.
6.4.7.1. Company Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Masimo
6.4.8.1. Company Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic initiatives
6.4.9. B. Braun Melsungen AG
6.4.9.1. Company Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic initiatives
6.4.10. ResMed
6.4.10.1. Company Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic initiatives
6.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
6.4.11.1. Company Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic initiatives
6.4.12. Inogen, Inc.
6.4.12.1. Company Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic initiatives
6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
6.4.13.1. Company Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic initiatives
6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical).
6.4.14.1. Company Overview
6.4.14.2. Financial Performance
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic initiatives
6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
6.4.15.1. Company Overview
6.4.15.2. Financial Performance
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic initiatives
6.4.16. O2 Concepts
6.4.16.1. Company Overview
6.4.16.2. Financial Performance
6.4.16.3. Product Benchmarking
6.4.16.4. Strategic initiatives
6.4.17. Nidek Medical Products, Inc.
6.4.17.1. Company Overview
6.4.17.2. Financial Performance
6.4.17.3. Product Benchmarking
6.4.17.4. Strategic initiatives
6.4.18. Omron Corporation
6.4.18.1. Company Overview
6.4.18.2. Financial Performance
6.4.18.3. Product Benchmarking
6.4.18.4. Strategic initiatives
6.4.19. GE Healthcare
6.4.19.1. Company Overview
6.4.19.2. Financial Performance
6.4.19.3. Product Benchmarking
6.4.19.4. Strategic initiatives
6.4.20. Allied Healthcare
6.4.20.1. Company Overview
6.4.20.2. Financial Performance
6.4.20.3. Product Benchmarking
6.4.20.4. Strategic initiatives
6.4.21. Vectura Group Plc.
6.4.21.1. Company Overview
6.4.21.2. Financial Performance
6.4.21.3. Product Benchmarking
6.4.21.4. Strategic initiatives
6.4.22. PARI Respiratory Equipment, Inc.
6.4.22.1. Company Overview
6.4.22.2. Financial Performance
6.4.22.3. Product Benchmarking
6.4.22.4. Strategic initiatives
6.4.23. Aerogen
6.4.23.1. Company Overview
6.4.23.2. Financial Performance
6.4.23.3. Product Benchmarking
6.4.23.4. Strategic initiatives
6.4.24. Beurer
6.4.24.1. Company Overview
6.4.24.2. Financial Performance
6.4.24.3. Product Benchmarking
6.4.24.4. Strategic initiatives
6.4.25. Briggs Healthcare
6.4.25.1. Company Overview
6.4.25.2. Financial Performance
6.4.25.3. Product Benchmarking
6.4.25.4. Strategic initiatives
List of Tables
Table 1 North America Anesthesia & Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 2 North America Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 3 U.S Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 4 Canada Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 5 Mexico Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 6 Europe Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 7 Europe Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 8 UK Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 9 Germany Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 10 France Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 11 Italy Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 12 Spain Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 13 Sweden Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 14 Denmark Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 15 Norway Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 16 Asia Pacific Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 17 Asia Pacific Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 18 China Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 19 Japan Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 20 India Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 21 Australia Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 22 South Korea Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 23 Thailand Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 24 Latin America Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 25 Latin America Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 26 Brazil Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 27 Argentina Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 28 MEA Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
Table 29 MEA Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 30 South Africa Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 31 Saudi Arabia Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 32 UAE Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
Table 33 Kuwait Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Aesthesia and respiratory devices market outlook
Fig. 9 Aesthesia and respiratory devices competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Aesthesia and respiratory devices market driver impact
Fig. 15 Aesthesia and respiratory devices market restraint impact
Fig. 16 Aesthesia and respiratory devices market strategic initiatives analysis
Fig. 17 Aesthesia and respiratory devices market: Product movement analysis
Fig. 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
Fig. 19 Anesthesia devices market, 2021 - 2033 (USD Million)
Fig. 20 Anesthesia delivery machines market, 2021 - 2033 (USD Million)
Fig. 21 Anesthesia monitors market, 2021 - 2033 (USD Million)
Fig. 22 Anesthesia ventilators market, 2021 - 2033 (USD Million)
Fig. 23 Anesthesia workstations market, 2021 - 2033 (USD Million)
Fig. 24 Anesthesia disposables market, 2021 - 2033 (USD Million)
Fig. 25 Anesthesia disposables masks market, 2021 - 2033 (USD Million)
Fig. 26 Anesthesia disposable accessories market, 2021 - 2033 (USD Million)
Fig. 27 Respiratory devices market, 2021 - 2033 (USD Million)
Fig. 28 Positive airway pressure market, 2021 - 2033 (USD Million)
Fig. 29 Ventilators market, 2021 - 2033 (USD Million)
Fig. 30 Nebulizers market, 2021 - 2033 (USD Million)
Fig. 31 Humidifiers market, 2021 - 2033 (USD Million)
Fig. 32 Respiratory inhalers market, 2021 - 2033 (USD Million)
Fig. 33 Oxygen concentrators market, 2021 - 2033 (USD Million)
Fig. 34 Reusable resuscitators market, 2021 - 2033 (USD Million)
Fig. 35 Pulse oximeters market, 2021 - 2033 (USD Million)Anesthesia Devices
Fig. 36 Capnographs market, 2021 - 2033 (USD Million)
Fig. 37 Spirometers market, 2021 - 2033 (USD Million)
Fig. 38 Peak flow meters market, 2021 - 2033 (USD Million)
Fig. 39 Global aesthesia and respiratory devices market: Regional movement analysis
Fig. 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
Fig. 41 Global anesthesia and respiratory devices market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Market share of key market players- aesthesia and respiratory devices market
Fig. 81 Key Company Categorization
Fig. 82 Company Market Share/Position Analysis, 2024
Fig. 83 Strategic Framework
